嘉实医药健康股票C(005304)资产负债表
| |
2025-12-31 |
2025-06-30 |
2024-12-31 |
2024-06-30 |
| 资产 |
| 银行存款 |
- |
- |
- |
- |
| 结算备付金 |
91,245.29 |
262,453.28 |
262,411.98 |
172,154.93 |
| 存出保证金 |
69,139.05 |
144,663.24 |
69,502.98 |
39,064.08 |
| 交易性金融资产 |
875,141,981.41 |
927,852,695.70 |
980,420,616.74 |
1,032,915,365.22 |
| 其中:股票投资 |
824,637,159.49 |
877,698,188.85 |
925,852,406.92 |
977,367,426.43 |
| 债券投资 |
50,504,821.92 |
50,154,506.85 |
54,568,209.82 |
55,547,938.79 |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
3,776,663.43 |
2,871,291.25 |
10,358,268.06 |
- |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
- |
98,740.07 |
- |
- |
| 应收申购款 |
520,747.49 |
322,797.88 |
124,546.25 |
310,863.05 |
| 其他资产 |
- |
- |
- |
- |
| 资产总计 |
889,812,293.45 |
996,158,668.47 |
1,028,754,140.97 |
1,068,362,871.89 |
| 负 债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
- |
7,426,868.58 |
- |
14,709.37 |
| 应付赎回款 |
4,412,612.13 |
1,857,537.90 |
2,991,565.40 |
834,448.73 |
| 应付管理人报酬 |
934,053.16 |
962,987.83 |
1,075,643.53 |
1,095,365.81 |
| 应付托管费 |
155,675.51 |
160,497.95 |
179,273.92 |
182,560.97 |
| 应付销售服务费 |
133,277.41 |
131,576.17 |
147,796.33 |
156,701.22 |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
- |
- |
24.93 |
- |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
135,130.10 |
357,351.08 |
198,869.48 |
304,793.36 |
| 负债合计 |
5,770,748.31 |
10,896,819.51 |
4,593,173.59 |
2,588,579.46 |
| 所有者权益 |
| 实收基金 |
522,394,278.42 |
625,433,871.30 |
760,404,939.95 |
810,963,839.09 |
| 未分配利润 |
361,647,266.72 |
359,827,977.66 |
263,756,027.43 |
254,810,453.34 |
| 所有者权益合计 |
884,041,545.14 |
985,261,848.96 |
1,024,160,967.38 |
1,065,774,292.43 |
| 负债及所有者权益总计 |
889,812,293.45 |
996,158,668.47 |
1,028,754,140.97 |
1,068,362,871.89 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年